Skip to main content

Table 1 Baseline demographic and clinical characteristics of the patients

From: A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome

Variable

Groups

P value

Control (N = 33)

Intervention (N = 34)

Gender (N; male/female)

9/24

13/21

0.44

Age (years; mean ± SD)

43.45 ± 10.35

44.41 ± 11.25

0.95

BMI (Kg/m2; mean ± SD)

22.71 ± 3.19

22.27 ± 2.95

0.57

IBS duration (Years; mean ± SD)

9.2 ± 7.74

10.0 ± 6.52

0.65

  1. BMI Body mass index, IBS Irritable bowel syndrome
Back to article page

BioPsychoSocial Medicine

ISSN: 1751-0759

Contact us